Cited by 374Skin and Cellular Biology ResearchHematopoietic Stem Cell TransplantationHair Growth and Disorders

Bone Marrow Transplantation for Recessive Dystrophic Epidermolysis Bullosa

Open access
Wagner, John E., Ishida-Yamamoto, Akemi, McGrath, John A., Hordinsky, Maria, Keene, Douglas R., Woodley, David T., Chen, Mei, Riddle, Megan J. +5 more·2010·New England Journal of Medicine

Abstract

BACKGROUND: Recessive dystrophic epidermolysis bullosa is an incurable, often fatal mucocutaneous blistering disease caused by mutations in COL7A1, the gene encoding type VII collagen (C7). On the basis of preclinical data showing biochemical correction and prolonged survival in col7 −/− mice, we hypothesized that allogeneic marrow contains stem cells capable of ameliorating the manifestations of recessive dystrophic epidermolysis bullosa in humans. METHODS: Between October 2007 and August 2009, we treated seven children who had recessive dystrophic epidermolysis bullosa with immunomyeloablative chemotherapy and allogeneic stem-cell transplantation. We assessed C7 expression by means of immunofluorescence staining and used transmission electron microscopy to visualize anchoring fibrils. We measured chimerism by means of competitive polymerase-chain-reaction assay, and documented blister formation and wound healing with the use of digital photography. RESULTS: One patient died of cardiomyopathy before transplantation. Of the remaining six patients, one had severe regimen-related cutaneous toxicity, with all having improved wound healing and a reduction in blister formation between 30 and 130 days after transplantation. We observed increased C7 deposition at the dermal-epidermal junction in five of the six recipients, albeit without normalization of anchoring fibrils. Five recipients were alive 130 to 799 days after transplantation; one died at 183 days as a consequence of graft rejection and infection. The six recipients had substantial proportions of donor cells in the skin, and none had detectable anti-C7 antibodies. CONCLUSIONS: Increased C7 deposition and a sustained presence of donor cells were found in the skin of children with recessive dystrophic epidermolysis bullosa after allogeneic bone marrow transplantation. Further studies are needed to assess the long-term risks and benefits of such therapy in patients with this disorder. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT00478244.)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa0910501

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A recent clinical trial reported improved wound healing and increased mechanical skin stability in children with RDEB after allogeneic bone marrow or umbilical cord blood transplantation.

    “A recent clinical trial reported improved wound healing and increased mechanical skin stability in children with recessive dystrophic epidermolysis bullosa (RDEB) after allogeneic bone marrow or umbilical cord blood transplantation (151).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [10]Fine JD Premature death in epidermolysis bullosa Fine JD Hinter H Life with epidermolysis bullosa (EB): etiology, diagnosis, multidisciplinary care and therapy New York Springer-Verlag 2009 197 203

Cited by

Sorted by citations

Authors
Wagner, J. E., Ishida-Yamamoto, A., McGrath, J. A., Hordinsky, M., Keene, D. R., Woodley, D. T., Chen, M., Riddle, M. J., Osborn, M. J., Lund, T., Dolan, M., Blazar, B. R., & Tolar, J.
Affiliations
University of Minnesota (US)
Venue
New England Journal of Medicine
Published
2010-08-12
Volume
363
Issue
7
Pages
629-639
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2098214526
Cited by
374
References
35
Citations by year
2026: 5 · 2025: 13 · 2024: 15 · 2023: 9 · 2022: 17 · 2021: 30 · 2020: 19 · 2019: 26 · 2018: 18 · 2017: 25 · 2016: 27 · 2015: 37 · 2014: 35 · 2013: 42 · 2012: 26
FWCI
13.42
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • National Heart, Lung, and Blood Institute (5R01-HL049997, R01HL049997)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR033625)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Medicine › Urology › Hair Growth and Disorders
Keywords
recessive dystrophic epidermolysis bullosa, allogeneic stem cell transplantation, bone marrow transplantation, type VII collagen, COL7A1, donor chimerism, anchoring fibrils, basement membrane zone, wound healing, graft rejection, pediatric patients
MeSH terms
Adolescent, Child, Child, Preschool, Female, Fetal Blood, Genes, Recessive, Graft Rejection, Humans, Male, Reticulin, Skin, Transplantation, Homologous, Bone Marrow Transplantation, Epidermolysis Bullosa Dystrophica, Transplantation Chimera, Transplantation Conditioning, Collagen Type VII, Microscopy, Electron, Transmission

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review